febuxostat has been researched along with Auricular Fibrillation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Borghi, C; Johnson, RJ; Kuwabara, M | 1 |
| Aonuma, K; Duo, F; Ieda, M; Li, S; Mori, H; Murakata, Y; Murakoshi, N; Nogami, A; Okabe, Y; Sato, A; Shimoda, Y; Song, Z; Tajiri, K; Xu, D; Yuan, Z | 1 |
| Ako, J; Fukaya, H; Igarashi, T; Kishihara, J; Murakami, M; Nakamura, H; Niwano, H; Niwano, S; Oikawa, J; Satoh, A; Tamaki, H; Yoshizawa, T | 1 |
| Cleveland, JD; Singh, JA | 1 |
| Masi, S; Pugliese, NR; Taddei, S | 1 |
| Chen, F; Deng, L; Li, Y; Lin, K; Shi, X; Wang, Y; Zhaoliang, S | 1 |
6 other study(ies) available for febuxostat and Auricular Fibrillation
| Article | Year |
|---|---|
Febuxostat and atrial fibrillation.
Topics: Aged; Allopurinol; Atrial Fibrillation; Febuxostat; Gout; Gout Suppressants; Humans; Medicare; United States | 2020 |
Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
Topics: Allopurinol; Animals; Atrial Fibrillation; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Connexins; Disease Models, Animal; Enzyme Inhibitors; Febuxostat; Fibrosis; Gap Junction alpha-5 Protein; Gap Junctions; Hypertension; Male; Myocytes, Cardiac; Oxidation-Reduction; Phosphorylation; Rats, Inbred Dahl; Ryanodine Receptor Calcium Release Channel; Sodium Chloride, Dietary; Xanthine Oxidase | 2021 |
Antiremodeling Effect of Xanthine Oxidase Inhibition in a Canine Model of Atrial Fibrillation.
Topics: Animals; Antioxidants; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Dogs; Echocardiography; Febuxostat; Female; Fibronectins; Fibrosis; Gout Suppressants; Heart Atria; Hemodynamics; Oxidative Stress; Reactive Oxygen Species; Xanthine Oxidase | 2018 |
Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data.
Topics: Aged; Allopurinol; Atrial Fibrillation; Cohort Studies; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Medicare; United States | 2019 |
The difficult relationship between uric acid and cardiovascular disease.
Topics: Aged; Allopurinol; Atrial Fibrillation; Cardiovascular Diseases; Febuxostat; Humans; Medicare; Risk Factors; United States; Uric Acid | 2019 |
Febuxostat attenuates paroxysmal atrial fibrillation-induced regional endothelial dysfunction.
Topics: Animals; Atrial Fibrillation; Endothelium; Enzyme Inhibitors; Febuxostat; Heart Atria; Male; Oxidative Stress; Rabbits; Xanthine Oxidase | 2017 |